Company Name
Takeda Pharmaceutical Company Limited
Tokyo Head Office
12-10, Nihonbashi 2-chome, Chuo-ku, Tokyo
103-8668
TEL: +81 3 3278-2111
FAX: +81 3 3278-2000
Head Ofiice
1-1, Doshomachi 4-chome, Chuo-ku, Osaka
540-8645
TEL: +81 6 6204-2111
FAX: +81 6 6204-2880
Founded
June 12, 1781
Incorporated
January 29, 1925
Representative Director
President & CEO: Christophe Weber
Paid-In Capital
¥65.7 billion *As of June 30, 2017
Number of Employees
6,638 (parent), 29,900 (consolidated) *As of March 31, 2017
Number of Shareholders
287,020 *As of March 31, 2017
Scope of Business
Research & Development, Manufacturing, Sales and Marketing, and Import/Export of Pharmaceutical Drugs, etc
R&D Sites
Tokyo, Osaka, Shonan, Hikari (Japan), Palo Alto, San Diego, Deerfield, Boston, Bozeman, Madison, Fort Collins (US), Rio de Janeiro (Brazil), Cambridge, London (U.K.), Singen (Germany), Zurich (Switzerland), Guangzhou, Shanghai (China), Singapore
Production Sites
Japan(Osaka, Hikari), Italy, Ireland, Germany, Austria, Denmark, Belgium, Norway, Poland, Russia, China, Indonesia, Mexico, Brazil, Argentina, Columbia, Estonia, India
Subsidiaries and affiliates
The Takeda Group consists 151 companies, including the parent company submitting these consolidated financial statements, 135 consolidated subsidiaries and 15 affiliates accounted for by the equity method *As of March 31, 2016
Shonan Research Center
26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa
251 - 8555
TEL: +81 -466- 32- 2111
Osaka Research Center
17-84, Jusohonmachi 2-chome, Yodogawa-ku, Osaka
532 – 8686
TEL: +81- 6- 6300- 6111